Characteristics of autoantibody-positive individuals without high-risk HLA-DR4-DQ8 or HLA-DR3-DQ2 haplotypes
Diabetologia · 2025-03 · 68 (3) · 588-601
DOI: 10.1007/s00125-024-06338-7 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diabetologia, online erschienen am 13.12.2024. Verfasst von Maria J Redondo und 12 weiteren Autor:innen. Beteiligte Einrichtung: Texas Children's Hospital, Department of Pediatrics, Baylor College of Medicine, Houston, TX, USA. redondo@bcm.edu. Hauptthemen laut MEDLINE: Autoantibodies, HLA-DQ Antigens, Diabetes Mellitus, Type 1, HLA-DR3 Antigen. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, NIH HHS, NCATS NIH HHS.
Abstract (Originalsprache)
Aims/hypothesis Many studies of type 1 diabetes pathogenesis focus on individuals with high-risk HLA haplotypes. We tested the hypothesis that, among islet autoantibody-positive individuals, lacking HLA-DRB1*04-DQA1*03-DQB1*0302 (HLA-DR4-DQ8) and/or HLA-DRB1*0301-DQA1*0501-DQB1*0201 (HLA-DR3-DQ2) is associated with phenotypic differences, compared with those who have these high-risk HLA haplotypes. Methods We classified autoantibody-positive relatives of individuals with type 1 diabetes into four groups based on having both HLA-DR4-DQ8 and HLA-DR3-DQ2 (DR3/DR4; n =1263), HLA-DR4-DQ8 but not HLA-DR3-DQ2 (DR4/non-DR3; n =2340), HLA-DR3-DQ2 but not HLA-DR4-DQ8 (DR3/non-DR4; n =1607) and neither HLA-DR3-DQ2 nor HLA-DR4-DQ8 (DRX/DRX; n =1294). Group comparisons included demographics, metabolic markers and the prevalence of autoantibodies against GAD65 (GADA%), IA-2 (IA-2A%) or insulin (IAA%) at enrolment. A p value
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Texas Children's Hospital, Department of Pediatrics, Baylor College of Medicine, Houston, TX, USA. redondo@bcm.edu.
- Health Informatics Institute, University of South Florida, Tampa, FL, USA.
- Barbara Davis Center for Diabetes, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.
- Immunobiology and Internal Medicine (Endocrinology), Yale University, New Haven, CT, USA.
- Clinical and Biomedical Sciences, University of Exeter, Exeter, UK.
- Departments of Pathology and Pediatrics, Diabetes Institute, College of Medicine, University of Florida, Gainesville, FL, USA.
Förderung
- NIAID NIH HHS
- NIH HHS
- NCATS NIH HHS
- NIDDK NIH HHS
- National Institute of Diabetes and Digestive and Kidney Diseases
- National Institutes of Health
- JDRF
Zitieren
APA
Redondo, M. J., Cuthbertson, D., Steck, A. K., Herold, K. C., Oram, R., Atkinson, M., Brusko, T. M., Parikh, H. M., Krischer, J. P., Onengut-Gumuscu, S., Rich, S. S., Sosenko, J. M., & Type 1 Diabetes TrialNet Study Group (2025). Characteristics of autoantibody-positive individuals without high-risk HLA-DR4-DQ8 or HLA-DR3-DQ2 haplotypes. Diabetologia, 68(3), 588-601. https://doi.org/10.1007/s00125-024-06338-7
Vancouver
Redondo MJ, Cuthbertson D, Steck AK, Herold KC, Oram R, Atkinson M, et al. Characteristics of autoantibody-positive individuals without high-risk HLA-DR4-DQ8 or HLA-DR3-DQ2 haplotypes. Diabetologia. 2025;68(3):588-601. doi:10.1007/s00125-024-06338-7
BibTeX
@article{Redondo2025,
author = {Redondo, Maria J and Cuthbertson, David and Steck, Andrea K and Herold, Kevan C and Oram, Richard and Atkinson, Mark and Brusko, Todd M and Parikh, Hemang M and Krischer, Jeffrey P and Onengut-Gumuscu, Suna and Rich, Stephen S and Sosenko, Jay M and Type 1 Diabetes TrialNet Study Group, Type 1 Diabetes TrialNet Study Group},
title = {Characteristics of autoantibody-positive individuals without high-risk HLA-DR4-DQ8 or HLA-DR3-DQ2 haplotypes},
journal = {Diabetologia},
year = {2025},
volume = {68},
number = {3},
pages = {588--601},
doi = {10.1007/s00125-024-06338-7}
}
EUVIMED